Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala.

Lange K, Marchiol A, Herazo R, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2025;
Download PDF
Publication

Piloting lymphoedema management for lymphatic filariasis: experiences and perceptions of patients and stakeholders from Kwale county, coastal Kenya

Kepha S, Were V, Okello G, et al. Springer Science and Business Media LLC. BMC Public Health. 2025; 25 (1) : 1-14.
Download PDF
Publication

A cross-sectional study of undergraduate pharmacy students’ awareness and knowledge of mycetoma

Ikeanyi CN, Onuigwe NP, Kuchazi BM, et al. Scientific Scholar. American Journal of Pharmacotherapy and Pharmaceutical Sciences. 2025;
Download PDF
Publication

Opportunities and barriers arising from the COVID-19 pandemic for health campaign integration across immunizations, neglected tropical diseases, insecticide-treated bed nets, and vitamin A supplementation: A qualitative key informant interview study

Krentel A, Rajabali A, Ogundahunsi O, et al. Public Library of Science (PLoS). PLOS Global Public Health. 2025; 5 (9) : 1-18.
Download PDF
Publication

Weekly epidemiological record: Elimination of human onchocerciasis: progress report, 2024–2025

World Health Organization . 2025;
Download PDF
Publication

Intestinal Parasitic Infections and Associated Risk Factors in Primary School Children in Isuikwuato Local Government Area, Abia State, Nigeria

Madubuike CN, Ukpai OM. Federal University Dutsin-Ma. Sahel Journal of Life Sciences FUDMA. 2025; 3 (3) : 197-207.
Download PDF
Publication

Factors associated with deaths due to visceral leishmaniasis among children at a hospital in the southwest of Maranhão state: a cross-sectional study, Imperatriz, 2010-2021

Teixeira MDMP, Santos DFD, Barros EA, et al. FapUNIFESP (SciELO). Epidemiologia e Serviços de Saúde. 2025;
Download PDF
Publication

Long-term trends of visceral leishmaniasis incidence and mortality in India 1990–2019: an application of joinpoint and age-period-cohort analysis

Dhamnetiya D, Bhattacharyya K, Jha RP, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2025; 25 (1) : 1-11.
Download PDF
Publication

Decline in prevalence and intensity of onchocerciasis in sentinel villages along the Comoé river in Cascades region, Burkina Faso following five years of community directed bi-annual ivermectin treatment, 2011–2015

Nikièma AS, Koala L, Unnasch TR, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2025; 25 (1) : 1-10.
Download PDF
Publication

Mainstreaming female genital schistosomiasis to ensure it is not neglected among the neglected tropical diseases

Mutapi F, Hietanen H, Mduluza T. Cambridge University Press (CUP). Parasitology. 2025;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD